-14.1%
MP vs MRNA
-24.9%
+10.8%
-82.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.0% | +1.3% | +0.7% | +1.8% |
| 7D | -2.1% | -13.8% | +11.7% | -0.7% |
| 30D | -6.1% | -17.7% | +11.5% | -4.6% |
| 3M | -35.3% | +14.3% | -49.6% | -36.9% |
| 6M | -33.3% | +336.0% | -369.2% | -51.0% |
| YTD | -27.4% | +575.9% | -603.4% | -53.2% |
| 1Y | -42.3% | +724.4% | -766.7% | -64.7% |
| 3Y | +126.6% | +160.8% | -34.2% | +73.0% |
| 5Y | -14.1% | -24.4% | +10.3% | -25.2% |
| All | -14.1% | -24.9% | +10.8% | -25.2% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling